Free Trial

Mariner LLC Buys Shares of 432,621 Marsh & McLennan Companies, Inc. $MRSH

Marsh & McLennan Companies logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • Mariner LLC disclosed a new fourth-quarter stake in Marsh & McLennan Companies, buying 432,621 shares valued at about $80.3 million. The position represented roughly 0.09% of the company.
  • Institutional ownership remains very high, with 87.99% of Marsh & McLennan shares held by institutions and hedge funds. Several other firms also opened small new positions during the quarter.
  • CEO John Q. Doyle sold 16,656 shares in a pre-arranged Rule 10b5-1 transaction, while the company reported stronger-than-expected quarterly results, including $3.29 EPS versus estimates of $3.21 and 7.6% revenue growth year over year.
  • Five stocks to consider instead of Marsh & McLennan Companies.

Mariner LLC bought a new stake in Marsh & McLennan Companies, Inc. (NYSE:MRSH - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 432,621 shares of the financial services provider's stock, valued at approximately $80,268,000. Mariner LLC owned approximately 0.09% of Marsh & McLennan Companies as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Solstein Capital LLC purchased a new position in shares of Marsh & McLennan Companies in the fourth quarter worth $25,000. KERR FINANCIAL PLANNING Corp purchased a new position in shares of Marsh & McLennan Companies in the fourth quarter worth $27,000. Golden State Wealth Management LLC purchased a new position in shares of Marsh & McLennan Companies in the fourth quarter worth $27,000. Atlas Capital Advisors Inc. purchased a new position in shares of Marsh & McLennan Companies in the fourth quarter worth $28,000. Finally, City Holding Co. purchased a new position in shares of Marsh & McLennan Companies in the fourth quarter worth $29,000. 87.99% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Marsh & McLennan Companies news, CEO John Q. Doyle sold 16,656 shares of Marsh & McLennan Companies stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $161.71, for a total value of $2,693,441.76. Following the completion of the transaction, the chief executive officer owned 116,811 shares of the company's stock, valued at approximately $18,889,506.81. The trade was a 12.48% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.38% of the company's stock.

Marsh & McLennan Companies Price Performance

Shares of Marsh & McLennan Companies stock opened at $166.06 on Tuesday. The company has a debt-to-equity ratio of 1.28, a current ratio of 1.11 and a quick ratio of 1.11. Marsh & McLennan Companies, Inc. has a 1 year low of $156.60 and a 1 year high of $220.32. The firm has a market cap of $80.22 billion, a P/E ratio of 20.76, a price-to-earnings-growth ratio of 2.46 and a beta of 0.62.

Marsh & McLennan Companies (NYSE:MRSH - Get Free Report) last released its quarterly earnings data on Thursday, April 16th. The financial services provider reported $3.29 earnings per share for the quarter, beating analysts' consensus estimates of $3.21 by $0.08. Marsh & McLennan Companies had a net margin of 14.26% and a return on equity of 31.87%. The company had revenue of $7.30 billion during the quarter. The firm's revenue for the quarter was up 7.6% compared to the same quarter last year. As a group, equities analysts expect that Marsh & McLennan Companies, Inc. will post 10.38 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the stock. Mizuho decreased their price target on shares of Marsh & McLennan Companies from $199.00 to $193.00 and set a "neutral" rating for the company in a report on Monday, April 13th. JPMorgan Chase & Co. reduced their target price on shares of Marsh & McLennan Companies from $226.00 to $206.00 and set an "overweight" rating for the company in a report on Thursday, April 9th. Raymond James Financial raised shares of Marsh & McLennan Companies from an "outperform" rating to a "strong-buy" rating and set a $225.00 target price for the company in a report on Tuesday, February 17th. Wells Fargo & Company reduced their target price on shares of Marsh & McLennan Companies from $203.00 to $178.00 and set an "equal weight" rating for the company in a report on Thursday, April 9th. Finally, Citigroup raised shares of Marsh & McLennan Companies from a "neutral" rating to a "buy" rating and set a $200.00 target price for the company in a report on Wednesday, May 6th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, ten have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average price target of $200.19.

Get Our Latest Stock Report on MRSH

Marsh & McLennan Companies Company Profile

(Free Report)

Marsh & McLennan Companies NYSE: MMC is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.

See Also

Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH - Free Report).

Institutional Ownership by Quarter for Marsh & McLennan Companies (NYSE:MRSH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Marsh & McLennan Companies Right Now?

Before you consider Marsh & McLennan Companies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marsh & McLennan Companies wasn't on the list.

While Marsh & McLennan Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines